CD8+ tissue-resident memory T cells (CD8+ TRM cells) residing in tumor tissues were found to be able to protect against cancer by secreting cytokines to prompt tumor-immune equilibrium and/or via CD103-enhanced tumor cell killing (27). This evidence concerns the gene ITGAE and neoplasm.